Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Acute poisoning with a membrane-stabilizing effect is potentially life-threatening. The principle drugs involved are tricyclic antidepressants, chloroquine, some types of beta blockers, class IA antiarrhythmics, carbamazepin and cocaine.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for acute poisoning by drugs with membrane-stabilizing effect.
2 publications have been identified in PubMed for acute poisoning by drugs with membrane-stabilizing effect. Research spans Review / Meta-Analysis (100%).
Nendumba G (2025). [PMID: 41247632](https://pubmed.ncbi.nlm.nih.gov/41247632/). *Annals of intensive care*. [Review / Meta-Analysis]
Torre DE (2025). [PMID: 40566578](https://pubmed.ncbi.nlm.nih.gov/40566578/). *Life (Basel, Switzerland)*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:38 AM UTC
European rare disease database
Common questions about acute poisoning by drugs with membrane-stabilizing effect